Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD

NCT00648245 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD
Chronic Obstructive Pulmonary Disease

Interventions

DRUG: BIO-11006 Inhalation Solution
DRUG: BIO-11006 Inhalation Solution
DRUG: BIO-11006 Inhalation Solution
DRUG: Placebo
DRUG: BIO-11006

Sponsor

BioMarck Pharmaceuticals, Ltd.

Collaborators

[object Object]